Literature DB >> 27051014

Increased expression of the lncRNA BANCR and its prognostic significance in human osteosarcoma.

Z Q Peng1, R B Lu2, D M Xiao3, Z M Xiao1.   

Abstract

Long noncoding RNAs (lncRNAs) play important roles in the formation and progression of many types of human malignancies. The aim of our study was to investigate the expression and biological functions of the lncRNA BRAF-activated noncoding RNA (BANCR) in human osteosarcoma. BANCR expression was quantified by real-time PCR in human osteosarcoma cell lines and tissues. We analyzed the association between BANCR levels and clinicopathological factors and patient prognosis. MTT, flow cytometric, and transwell invasion assays were performed to observe the effects of BANCR on MG-63 cell biological behaviors. BANCR overexpression was observed in osteosarcoma cell lines and clinical specimens. Increased BANCR expression was significantly associated with large tumor size, positive distant metastasis, and advanced clinical stage. High BANCR expression in osteosarcoma was an independent predictor of poor survival. Downregulation of BANCR inhibited MG-63 cell proliferation and invasion and promoted cell apoptosis in vitro. These findings suggested that BANCR may act as a tumor promoter in osteosarcoma and could serve as a potential therapeutic target for this disease.

Entities:  

Year:  2016        PMID: 27051014     DOI: 10.4238/gmr.15017480

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  18 in total

1.  Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.

Authors:  Jing Jiang; Sheng-Hong Shi; Xu-Jun Li; Long Sun; Qi-Dong Ge; Chao Li; Wei Zhang
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

2.  Long non-coding RNA CASC15 promotes tongue squamous carcinoma progression through targeting miR-33a-5p.

Authors:  Zhibin Zuo; Long Ma; Zuode Gong; Lande Xue; Qibao Wang
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-26       Impact factor: 4.223

3.  Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression.

Authors:  Jiang-Hua Dai; Wen-Zhou Huang; Chen Li; Jun Deng; Si-Jian Lin; Jun Luo
Journal:  Cell Cycle       Date:  2019-08-21       Impact factor: 4.534

4.  LINC00662 Long Non-Coding RNA Knockdown Attenuates the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Regulating the microRNA-15a-5p/Notch2 Axis.

Authors:  Shuheng Liu; Xianghai Meng
Journal:  Onco Targets Ther       Date:  2020-08-10       Impact factor: 4.147

Review 5.  The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies.

Authors:  Xiu-Fen Liu; Ji-Long Hao; Tian Xie; Om Prakash Pant; Cheng-Bo Lu; Cheng-Wei Lu; Dan-Dan Zhou
Journal:  Cell Prolif       Date:  2018-02-27       Impact factor: 6.831

6.  Altered long non-coding RNAs predict worse outcome in osteosarcoma patients: evidence from a meta-analysis.

Authors:  Yanliang Yang; Shunli Wang; Teng Li
Journal:  Oncotarget       Date:  2017-05-23

Review 7.  Long non-coding RNAs in osteosarcoma.

Authors:  Ruiling Chen; Gangyang Wang; Ying Zheng; Yingqi Hua; Zhengdong Cai
Journal:  Oncotarget       Date:  2017-03-21

Review 8.  BRAF-activated lncRNA predicts gastrointestinal cancer patient prognosis: a meta-analysis.

Authors:  Yang-Hua Fan; Min-Hua Ye; Lei Wu; Miao-Jing Wu; Shi-Gang Lu; Xin-Gen Zhu
Journal:  Oncotarget       Date:  2017-01-24

9.  Long noncoding RNA DNAJC3-AS1 promotes osteosarcoma progression via its sense-cognate gene DNAJC3.

Authors:  Ridong Liang; Zezheng Liu; Zhixu Chen; Yang Yang; Yuejun Li; Zhifei Cui; Ajuan Chen; Zhenxue Long; Jinbin Chen; Jiachun Lu; Bin Huang; Qingchu Li
Journal:  Cancer Med       Date:  2019-01-16       Impact factor: 4.452

10.  Abnormally expressed long non-coding RNAs in prognosis of Osteosarcoma: A systematic review and meta-analysis.

Authors:  Delong Chen; Haibin Wang; Meng Zhang; Shan Jiang; Chi Zhou; Bin Fang; Peng Chen
Journal:  J Bone Oncol       Date:  2018-09-22       Impact factor: 4.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.